Oct 09, 2020 8:00am EDT OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools
Oct 08, 2020 11:38am EDT Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
Sep 02, 2020 8:00am EDT OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program
Sep 01, 2020 3:55pm EDT OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay
Aug 12, 2020 11:20am EDT OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services
Jul 30, 2020 4:05pm EDT OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results